Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002

Pediatrics

Volumn 116, Issue 3, 2005, Pages 580-586

  Williams, Laura J ^a   Rasmussen, Sonja A ^a,c   Flores, Alina ^a   Kirby, Russell S ^b   Edmonds, Larry D ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Anencephaly; Folic acid; Fortification; Neural tube defects; Race ethnicity; Spina bifida

Indexed keywords

ANENCEPHALUS; ARTICLE; BIRTH DEFECT; CONTROLLED STUDY; DISEASE CONTROL; ETHNOLOGY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SPINA BIFIDA; UNITED STATES; CAUCASIAN; DIET SUPPLEMENTATION; ETHNIC GROUP; FEMALE; HISPANIC; NEGRO; NEURAL TUBE DEFECT; PREGNANCY; PRENATAL CARE; PUERTO RICO; RACE; STATISTICS;

FOLIC ACID;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANENCEPHALY; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HISPANIC AMERICANS; HUMANS; PREGNANCY; PRENATAL CARE; PREVALENCE; PUERTO RICO; SPINAL DYSRAPHISM; UNITED STATES;

EID: 27644444975     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2005-0592     Document Type: Article

References (55)

1. Centers for Disease Control and Prevention. Spina bifida and anencephaly before and after folic acid mandate-United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep. 2004;53:362-365
2. Hendricks KA, Simpson JS, Larsen RD. Neural tube defects along the Texas-Mexico border, 1993-1995. Am J Epidemiol. 1999;149:1119-1127
3. Cragan JD, Roberts HE, Edmonds LD, et al. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis-United States, 1985-1994. MMWR Morb Mortal Wkly Rep. 1995;44:1-13
4. Canfield MA, Annegers JF, Brender JD, Cooper SP, Greenberg F. Hispanic origin and neural tube defects in Houston/Harris County, Texas. I. Descriptive epidemiology. Am J Epidemiol. 1996;143:1-11
5. Feldman JG, Stein SC, Klein RJ, Kohl S, Casey G. The prevalence of neural tube defects among ethnic groups in Brooklyn, New York. J Chron Dis. 1982;35:53-60
6. Feuchtbaum LB, Currier RJ, Riggle S, Roberson M, Lorey FW, Cunningham GC. Neural tube defect prevalence in California (1990 -1994): eliciting patterns by type of defect and maternal race/ethnicity. Genet Test. 1999;3:265-272
7. Elwood JM, Little J, Elwood JH. Epidemiology and Control of Neural Tube Defects. Oxford, England: Oxford University Press; 1992
8. Carmichael SL, Shaw GM, Kaidarova Z. Congenital malformations in offspring of Hispanic and African-American women in California, 1989-1997. Birth Defects Res A Clin Mol Teratol. 2004;70:382-388
9. Kirby R, Petrini J, Alter C. Collecting and interpreting birth defects surveillance data by Hispanic ethnicity: a comparative study. The Hispanic Ethnicity Birth Defects Workgroup. Teratology. 2000;61:21-27
10. Ray JG, Vermeulen RJ, Meier C, Cole DE, Wyatt PR. Maternal ethnicity and risk of neural tube defects: a population-based study. CMAJ. 2004;171:343-345
11. Shaw GM, Velie EM, Wasserman CR. Risk for neural tube defect-affected pregnancies among women of Mexican descent and white women in California. Am J Public Health. 1997;87:1467-1471
12. Centers for Disease Control and Prevention. Spina bifida incidence at birth-United States, 1983-1990. MMWR Morb Mortal Wkly Rep. 1992;41:497-500
13. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-1835
14. Medical Research Council. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet. 1991;338:131-137
15. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999;341:1485-1490
16. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Reg. 1996;61:8781-8797
17. Williams LJ, Mai CT, Edmonds LD, et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology. 2002;66:33-39
18. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 2001;285:2981-2986
19. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med. 1999;341:1509-1519
20. Centers for Disease Control and Prevention. Statistical Analysis Battery for Epidemiological Research (SABER). Available at: www.cdc.gov/nceh/ publications/saber/saber.htm. Accessed August 20, 2004
21. Siega-Riz AM, Bodnar LM, Savitz DA. What are pregnant women eating? Nutrient and food group differences by race. Am J Obstet Gynecol. 2002;186:480-486
22. Jasti S, Siega-Riz AM, Bentley ME. Dietary supplement use in the context of health disparities: cultural, ethnic and demographic determinants of use. J Nutr. 2003;133:2010S-2013S
23. Ford ES, Ballew C. Dietary folate intake in US adults: findings from the third National Health and Nutrition Examination Survey. Ethn Dis. 1998;8:299-305
24. Timbo B, Altekruse S, Hyman F, Klontz K, Tollefson L. Vitamin and mineral supplementation during pregnancy. Mil Med. 1994;159:654-658
25. Canfield MA, Anderson JL, Waller DK, Palmer SE, Kaye CI. Folic acid awareness and use among women with a history of neural tube defect pregnancy-Texas, 2000-2001. MMWR Morb Mortal Wkly Rep. 2002;51:16-19
26. Ahluwalia IB, Lyon Daniel K. Are women with recent live births aware of the benefits of folic acid? MMWR Morb Mortal Wkly Rep. 2001;50:3-14
27. Perlow JH. Comparative use and knowledge of preconceptional folic acid among Spanish- and English-speaking patient populations in Phoenix and Yuma, Arizona. Am J Obstet Gynecol. 2001;184:1263-1266
28. Siega-Riz AM, Popkin BM, Carson T. Differences in food patterns at breakfast by sociodemographic characteristics among a nationally representative sample of adults in the United States. Prev Med. 2000;30:415-424
29. Dary O. Lessons learned with iron fortification in Central America. Nutr Rev. 2002;60:S30-S33
30. Centers for Disease Control and Prevention. Folate status in women of childbearing age, by race/ethnicity-United States, 1999-2000. MMWR Morb Mortal Wkly Rep. 2002;51:808-810
31. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000;151:862-877
32. Esfahani ST, Cogger EA, Caudill MA. Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups. J Am Diet Assoc. 2003;103:200-207
33. Wilcken B, Bamforth F, Li Z, et al. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet. 2003;40:619-625
34. Barber R, Shalat S, Hendricks K, et al. Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas Hispanic population. Mol Genet Metab. 2000;70:45-52
35. O'Leary VB, Mills JL, Kirke PN, et al. Analysis of the human folate receptor beta gene for an association with neural tube defects. Mol Genet Metab. 2003;79:129-133
36. Zhu H, Junker WM, Finnell RH, et al. Lack of association between ZIC2 and ZIC3 genes and the risk of neural tube defects (NTDs) in Hispanic populations. Am J Med Genet. 2003;116A:414-415
37. Zhu H, Wicker NJ, Volcik K, et al. Promoter haplotype combinations for the human PDGFRA gene are associated with risk of neural tube defects. Mol Genet Metab. 2004;81:127-132
38. Volcik KA, Zhu H, Finnell RH, Shaw GM, Canfield M, Lammer EJ. Evaluation of the jumonji gene and risk for spina bifida and congenital heart defects. Am J Med Genet. 2004;126A:215-217
39. Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics. 1990;85:1-9
40. Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics. 2003;111:1152-1158
41. Suarez L, Hendricks K, Felkner M, Gunter E. Maternal serum B12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann Epidemiol. 2003;13:81-88
42. Ray JG, Blom HJ. Vitamin B12 insufficiency and the risk of fetal neural tube defects. QJM. 2003;96:289-295
43. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004;291:2847-2850
44. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-79
45. Wright JD, Bialostosky K, Gunter EW, et al. Blood folate and vitamin B12: United States, 1988-94. Vital Health Stat 11. 1998;1-78
46. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology. 1995;6:219-226
47. Suarez L, Hendricks KA, Cooper SP, Sweeney AM, Hardy RJ, Larsen RD. Neural tube defects among Mexican Americans living on the US-Mexico border: effects of folic acid and dietary folate. Am J Epidemiol. 2000;152:1017-1023
48. Hertrampf E, Cortes F. Folic acid fortification of wheat flour: Chile. Nutr Rev. 2004;62:S44-S48
49. Martinez de Villarreal L, Perez JZ, et al. Decline of neural tube defects cases after a folic acid campaign in Nuevo Leon, Mexico. Teratology. 2002;66:249-256
50. Chen LT, Rivera MA. The Costa Rican experience: reduction of neural tube defects following food fortification programs. Nutr Rev. 2004;62:S40-S43
51. Baker D, Teklehaimanot S, Hassan R, Guze C. A look at a Hispanic and African American population in an urban prenatal diagnostic center: referral reasons, amniocentesis acceptance, and abnormalities detected. Genet Med. 2004;6:211-218
52. Peller AJ, Westgate MN, Holmes LB. Trends in congenital malformations, 1974-1999: effect of prenatal diagnosis and elective termination. Obstet Gynecol. 2004;104:957-964
53. Siffel C, Correa A, Cragan JD, Alverson CJ. Prenatal diagnosis, pregnancy terminations and prevalence of Down syndrome in Atlanta. Birth Defects Res A Clin Mol Teratol. 2004;70:565-571
54. Tumiel LM, Buck GM, Zayas LE, Jaen CR. Unmasking adverse birth outcomes among Hispanic subgroups. Ethn Dis. 1998;8:209-217
55. Yoon PW, Rasmussen SA, Lynberg MC, et al. The National Birth Defects Prevention Study. Public Health Rep. 2001;116(suppl 1):32-40